Literature DB >> 18669916

Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease.

Vered Padler-Karavani1, Hai Yu, Hongzhi Cao, Harshal Chokhawala, Felix Karp, Nissi Varki, Xi Chen, Ajit Varki.   

Abstract

Human heterophile antibodies that agglutinate animal erythrocytes are known to detect the nonhuman sialic acid N-glycolylneuraminic acid (Neu5Gc). This monosaccharide cannot by itself fill the binding site (paratope) of an antibody and can also be modified and presented in various linkages, on diverse underlying glycans. Thus, we hypothesized that the human anti-Neu5Gc antibody response is diverse and polyclonal. Here, we use a novel set of natural and chemoenzymatically synthesized glycans to show that normal humans have an abundant and diverse spectrum of such anti-Neu5Gc antibodies, directed against a variety of Neu5Gc-containing epitopes. High sensitivity and specificity assays were achieved by using N-acetylneuraminic acid (Neu5Ac)-containing probes (differing from Neu5Gc by one less oxygen atom) as optimal background controls. The commonest anti-Neu5Gc antibodies are of the IgG class. Moreover, the range of reactivity and Ig classes of antibodies vary greatly amongst normal humans, with some individuals having remarkably large amounts, even surpassing levels of some well-known natural blood group and xenoreactive antibodies. We purified these anti-Neu5Gc antibodies from individual human sera using a newly developed affinity method and showed that they bind to wild-type but not Neu5Gc-deficient mouse tissues. Moreover, they bind back to human carcinomas that have accumulated Neu5Gc in vivo. As dietary Neu5Gc is primarily found in red meat and milk products, we suggest that this ongoing antigen-antibody reaction may generate chronic inflammation, possibly contributing to the high frequency of diet-related carcinomas and other diseases in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669916      PMCID: PMC2586336          DOI: 10.1093/glycob/cwn072

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  66 in total

1.  A multifunctional Pasteurella multocida sialyltransferase: a powerful tool for the synthesis of sialoside libraries.

Authors:  Hai Yu; Harshal Chokhawala; Rebekah Karpel; Hui Yu; Bingyuan Wu; Jianbo Zhang; Yingxin Zhang; Qiang Jia; Xi Chen
Journal:  J Am Chem Soc       Date:  2005-12-21       Impact factor: 15.419

2.  THE HETEROPHILE ANTIBODIES IN INFECTIOUS MONONUCLEOSIS AND AFTER THE INJECTION OF SERUM.

Authors:  P Beer
Journal:  J Clin Invest       Date:  1936-11       Impact factor: 14.808

3.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.

Authors:  G R Siber; P H Schur; A C Aisenberg; S A Weitzman; G Schiffman
Journal:  N Engl J Med       Date:  1980-07-24       Impact factor: 91.245

Review 4.  Comparative enzymology, biochemistry and pathophysiology of human exo-alpha-sialidases (neuraminidases).

Authors:  K E Achyuthan; A M Achyuthan
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2001-05       Impact factor: 2.231

5.  Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.

Authors:  Muriel Bardor; Dzung H Nguyen; Sandra Diaz; Ajit Varki
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

Review 6.  Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours.

Authors:  Akira Kobata; Junko Amano
Journal:  Immunol Cell Biol       Date:  2005-08       Impact factor: 5.126

7.  Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

Authors:  S Zhang; L A Walberg; S Ogata; S H Itzkowitz; R R Koganty; M Reddish; S S Gandhi; B M Longenecker; K O Lloyd; P O Livingston
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

8.  Cancer mortality surveillance--United States, 1990-2000.

Authors:  Sherri L Stewart; Jessica B King; Trevor D Thompson; Carol Friedman; Phyllis A Wingo
Journal:  MMWR Surveill Summ       Date:  2004-06-04

9.  Efficient chemoenzymatic synthesis of biotinylated human serum albumin-sialoglycoside conjugates containing O-acetylated sialic acids.

Authors:  Hai Yu; Harshal A Chokhawala; Ajit Varki; Xi Chen
Journal:  Org Biomol Chem       Date:  2007-06-27       Impact factor: 3.876

10.  A new homobifunctional p-nitro phenyl ester coupling reagent for the preparation of neoglycoproteins.

Authors:  Xiangyang Wu; Chang-Chun Ling; David R Bundle
Journal:  Org Lett       Date:  2004-11-25       Impact factor: 6.005

View more
  105 in total

1.  Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.

Authors:  Marjolein M P Oerlemans; Sam J Moons; Jurriaan J A Heming; Thomas J Boltje; Marien I de Jonge; Jeroen D Langereis
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.

Authors:  Mylène A Carrascal; Paulo F Severino; M Guadalupe Cabral; Mariana Silva; José Alexandre Ferreira; Fernando Calais; Hermínia Quinto; Cláudia Pen; Dário Ligeiro; Lúcio Lara Santos; Fabio Dall'Olio; Paula A Videira
Journal:  Mol Oncol       Date:  2014-03-06       Impact factor: 6.603

3.  Sequential two-step multienzyme synthesis of tumor-associated sialyl T-antigens and derivatives.

Authors:  Kam Lau; Hai Yu; Vireak Thon; Zahra Khedri; Meghan E Leon; Bao K Tran; Xi Chen
Journal:  Org Biomol Chem       Date:  2011-03-01       Impact factor: 3.876

4.  The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.

Authors:  Christoph Schneider; David F Smith; Richard D Cummings; Kayluz Frias Boligan; Robert G Hamilton; Bruce S Bochner; Sylvia Miescher; Hans-Uwe Simon; Anastas Pashov; Tchavdar Vassilev; Stephan von Gunten
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

5.  Sugar-binding proteins from fish: selection of high affinity "lambodies" that recognize biomedically relevant glycans.

Authors:  Xia Hong; Mark Z Ma; Jeffrey C Gildersleeve; Sudipa Chowdhury; Joseph J Barchi; Roy A Mariuzza; Michael B Murphy; Li Mao; Zeev Pancer
Journal:  ACS Chem Biol       Date:  2012-10-08       Impact factor: 5.100

Review 6.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261

7.  One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.

Authors:  Hamed Malekan; Gabriel Fung; Vireak Thon; Zahra Khedri; Hai Yu; Jingyao Qu; Yanhong Li; Li Ding; Kit S Lam; Xi Chen
Journal:  Bioorg Med Chem       Date:  2013-03-07       Impact factor: 3.641

8.  Sialic acid speciation using capillary electrophoresis: optimization of analyte derivatization and separation.

Authors:  Zoltan Szabo; Jonathan Bones; Andras Guttman; James Glick; Barry L Karger
Journal:  Anal Chem       Date:  2012-08-29       Impact factor: 6.986

9.  Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.

Authors:  Rachel E Taylor; Christopher J Gregg; Vered Padler-Karavani; Darius Ghaderi; Hai Yu; Shengshu Huang; Ricardo U Sorensen; Xi Chen; Jaime Inostroza; Victor Nizet; Ajit Varki
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

10.  Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products.

Authors:  Sandra L Diaz; Vered Padler-Karavani; Darius Ghaderi; Nancy Hurtado-Ziola; Hai Yu; Xi Chen; Els C M Brinkman-Van der Linden; Ajit Varki; Nissi M Varki
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.